fda approval for semaglutide approves first-ever oral GLP-1RA obesity and chronic weight management. Meet Wegovy (semaglutide) tablets. https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults Oral Semaglutide Gets FDA Approval

This complete absence of tolerability-driven discontinuations indicates that even when side effects occurred, they were sufficiently mild that participants chose to continue treatment

Retatrutide The next generation of weight loss medications is already in clinical trials

The researchers found that the increased hair loss was largely non-scarring alopecia, where the follicles remain intact and the hair can grow back

Data collection and study outcomes Patients were identified from an electronic medical record report identifying an active prescription for oral or injectable semaglutide during the study period

Theres limited research on the overall effect of Ozempic on periods

What Do Early Results Show